Compare Abeona Therapeutics Inc (ABEO) vs Macy's Inc (M) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Macy's Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Macy's Inc trades at $24.53 (market cap $6.45B). The key difference: Macy's Inc is far larger — about 15.3× Abeona Therapeutics Inc's market cap, and Macy's Inc pays a 3.12% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | M | |
|---|---|---|
Market Cap | $421.19M | $6.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $26.21 |
52-Week Low | $4.17 | $12.73 |
Enterprise Value | $276.10M | $10.26B |
Dividend Yield | — | 3.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →
